Your browser doesn't support javascript.
loading
Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.
Banchereau, Romain; Chitre, Avantika S; Scherl, Alexis; Wu, Thomas D; Patil, Namrata S; de Almeida, Patricia; Kadel Iii, Edward E; Madireddi, Shravan; Au-Yeung, Amelia; Takahashi, Chikara; Chen, Ying-Jiun; Modrusan, Zora; McBride, Jacqueline; Nersesian, Rhea; El-Gabry, Ehab A; Robida, Mark D; Hung, Jeffrey C; Kowanetz, Marcin; Zou, Wei; McCleland, Mark; Caplazi, Patrick; Eshgi, Shadi Toghi; Koeppen, Hartmut; Hegde, Priti S; Mellman, Ira; Mathews, W Rodney; Powles, Thomas; Mariathasan, Sanjeev; Grogan, Jane; O'Gorman, William E.
Afiliación
  • Banchereau R; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • Chitre AS; Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA.
  • Scherl A; Department of Research Pathology, Genentech Inc, South San Francisco, California, USA.
  • Wu TD; Department of Bioinformatics and Computational Biology, Genentech Inc, South San Francisco, California, USA.
  • Patil NS; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • de Almeida P; Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA.
  • Kadel Iii EE; Adaptive Biotechnologies Corp South San Francisco, South San Francisco, California, USA.
  • Madireddi S; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • Au-Yeung A; Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA.
  • Takahashi C; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • Chen YJ; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • Modrusan Z; Department of Microchemistry, Proteomics, Lipidomics, and Next Generation Sequencing, Genentech Inc, South San Francisco, California, USA.
  • McBride J; Analytical Biosciences Limited, South San Francisco, California, USA.
  • Nersesian R; Department of Microchemistry, Proteomics, Lipidomics, and Next Generation Sequencing, Genentech Inc, South San Francisco, California, USA.
  • El-Gabry EA; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • Robida MD; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • Hung JC; Ventana Medical Systems Inc, Tucson, Arizona, USA.
  • Kowanetz M; Ventana Medical Systems Inc, Tucson, Arizona, USA.
  • Zou W; Department of Research Pathology, Genentech Inc, South San Francisco, California, USA.
  • McCleland M; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • Caplazi P; Bolt Biotherapeutics, Redwood City, California, USA.
  • Eshgi ST; Department of Biostatistics Oncology, Genentech Inc, South San Francisco, California, USA.
  • Koeppen H; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • Hegde PS; Department of Research Pathology, Genentech Inc, South San Francisco, California, USA.
  • Mellman I; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • Mathews WR; Department of Research Pathology, Genentech Inc, South San Francisco, California, USA.
  • Powles T; Foundation Medicine, Cambridge, Massachusetts, USA.
  • Mariathasan S; Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA.
  • Grogan J; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA.
  • O'Gorman WE; Barts Cancer Center, Queen Mary University, London, UK.
J Immunother Cancer ; 9(4)2021 04.
Article en En | MEDLINE | ID: mdl-33827905
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Biomarcadores de Tumor / Antígenos CD / Linfocitos Infiltrantes de Tumor / Linfocitos T CD8-positivos / Cadenas alfa de Integrinas / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Biomarcadores de Tumor / Antígenos CD / Linfocitos Infiltrantes de Tumor / Linfocitos T CD8-positivos / Cadenas alfa de Integrinas / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido